WO2001075443A3 - Method and reagents for investigating functional molecular interactions - Google Patents

Method and reagents for investigating functional molecular interactions Download PDF

Info

Publication number
WO2001075443A3
WO2001075443A3 PCT/US2001/010506 US0110506W WO0175443A3 WO 2001075443 A3 WO2001075443 A3 WO 2001075443A3 US 0110506 W US0110506 W US 0110506W WO 0175443 A3 WO0175443 A3 WO 0175443A3
Authority
WO
WIPO (PCT)
Prior art keywords
binding
members
molecular interactions
relates
reagents
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2001/010506
Other languages
French (fr)
Other versions
WO2001075443A2 (en
Inventor
Thomas G Consler
John G Gray
Marie A Iannone
Julie B Stimmel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Priority to JP2001572869A priority Critical patent/JP2003529767A/en
Priority to EP01922998A priority patent/EP1282818A2/en
Priority to AU2001249738A priority patent/AU2001249738A1/en
Publication of WO2001075443A2 publication Critical patent/WO2001075443A2/en
Anticipated expiration legal-status Critical
Publication of WO2001075443A3 publication Critical patent/WO2001075443A3/en
Ceased legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54313Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
    • G01N33/54346Nanoparticles
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/585Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with a particulate label, e.g. coloured latex
    • G01N33/587Nanoparticles

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Nanotechnology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Steroid Compounds (AREA)

Abstract

The present invention provides a multiplexed assay for analyzing complex molecular interactions. Thus, the invention relates to a method of identifying, in a single assay, the relative binding of two or more first members of a binding pair to one or more second members of a binding pair. The invention also relates to a method of identifying, in a single assay, the relative modulation, by a modulating agent, of binding between two or more binding pairs or between two or more binding complexes. Further provided are methods of screening, in a single assay, for an agent or agents with a selected binding profile or for an agent that modulates binding between two or more first members of a binding pair and one or more second members of a binding pair or the members of two or more binding complexes. The invention also relates to a set of microspheres coupled with a set of cofactors, wherein the microspheres are labeled with a label specific for each cofactor of the set.
PCT/US2001/010506 2000-03-31 2001-03-30 Method and reagents for investigating functional molecular interactions Ceased WO2001075443A2 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
JP2001572869A JP2003529767A (en) 2000-03-31 2001-03-30 Method for testing functional molecular interaction and reagent for use therein
EP01922998A EP1282818A2 (en) 2000-03-31 2001-03-30 Method and reagents for investigating functional molecular interactions
AU2001249738A AU2001249738A1 (en) 2000-03-31 2001-03-30 Method and reagents for investigating functional molecular interactions

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US19382600P 2000-03-31 2000-03-31
US60/193,826 2000-03-31

Publications (2)

Publication Number Publication Date
WO2001075443A2 WO2001075443A2 (en) 2001-10-11
WO2001075443A3 true WO2001075443A3 (en) 2002-11-28

Family

ID=22715172

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2001/010506 Ceased WO2001075443A2 (en) 2000-03-31 2001-03-30 Method and reagents for investigating functional molecular interactions

Country Status (4)

Country Link
EP (1) EP1282818A2 (en)
JP (1) JP2003529767A (en)
AU (1) AU2001249738A1 (en)
WO (1) WO2001075443A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002357289A1 (en) * 2001-12-21 2003-07-15 Centocor, Inc. A novel screening method for molecular antagonist using flow-cytometry
EP1353182A3 (en) * 2002-04-12 2004-02-04 Smithkline Beecham Corporation Method of predicting cell-based assay results using binding profiles
WO2003087132A2 (en) * 2002-04-12 2003-10-23 Smithkline Beecham Corporation Compositions and methods for evaluating and designing nuclear receptor ligands that modulate co-regulator affinity

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4510244A (en) * 1980-04-17 1985-04-09 The Board Of Trustees Of The Leland Stanford Jr. University Cell labeling with antigen-coupled microspheres
EP0617286A2 (en) * 1993-03-18 1994-09-28 Wallac Oy Biospecific solid phase carrier
US5858648A (en) * 1996-11-04 1999-01-12 Sienna Biotech, Inc. Assays using reference microparticles
US5876946A (en) * 1997-06-03 1999-03-02 Pharmacopeia, Inc. High-throughput assay
US5891738A (en) * 1995-01-16 1999-04-06 Erkki Soini Biospecific multiparameter assay method
WO1999036564A1 (en) * 1998-01-16 1999-07-22 Luminex Corporation Multiplexed analysis of clinical specimens apparatus and methods

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4510244A (en) * 1980-04-17 1985-04-09 The Board Of Trustees Of The Leland Stanford Jr. University Cell labeling with antigen-coupled microspheres
EP0617286A2 (en) * 1993-03-18 1994-09-28 Wallac Oy Biospecific solid phase carrier
US5891738A (en) * 1995-01-16 1999-04-06 Erkki Soini Biospecific multiparameter assay method
US5858648A (en) * 1996-11-04 1999-01-12 Sienna Biotech, Inc. Assays using reference microparticles
US5876946A (en) * 1997-06-03 1999-03-02 Pharmacopeia, Inc. High-throughput assay
WO1999036564A1 (en) * 1998-01-16 1999-07-22 Luminex Corporation Multiplexed analysis of clinical specimens apparatus and methods

Also Published As

Publication number Publication date
EP1282818A2 (en) 2003-02-12
WO2001075443A2 (en) 2001-10-11
JP2003529767A (en) 2003-10-07
AU2001249738A1 (en) 2001-10-15

Similar Documents

Publication Publication Date Title
WO2003073817A3 (en) Rapid and sensitive detection of cells and viruses
AU4932099A (en) Methods for fractional quantification of cholesterol in lipoproteins and quantification reagents
WO2003003015A3 (en) Methods of preparing multicolor quantum dot tagged beads and conjugates thereof
WO2004051218A8 (en) Multiplex amplification of polynucleotides
WO2003050295A3 (en) Assays and implements for determining and modulating hsp90 binding activity
WO2005046859A3 (en) System and method for carrying out multiple binding reactions in an array format
WO2002004918A3 (en) Nanoporous membrane immunosensor
CA2413978A1 (en) Multianalyte molecular analysis
WO1997027325A3 (en) Methods and compositions for analyzing nucleic acid molecules utilizing sizing techniques
AU2002952797A0 (en) Centrifugal device and method using same
WO2002037102A3 (en) Methods for analyzing dynamic changes in cellular informatics
WO2002077762A3 (en) System and method for providing personalized customer support
MXPA04001730A (en) A method for the determination of multiple analytes.
WO2002048838A3 (en) Business method for a marketing strategy
WO2001075443A3 (en) Method and reagents for investigating functional molecular interactions
WO2003106649A3 (en) Assay conjugate and uses thereof
AU3534001A (en) Method for identifying a mark applied on a solid body
WO2002066954A3 (en) Pdz domain interactions and lipid rafts
WO2005059517A3 (en) Toll-like receptor assays
WO2002031179A3 (en) Multiplex assays using nanoparticles
WO2004081531A8 (en) Ligand analysis
DK1262778T3 (en) Method for differentiated labeling using platinum complexes
WO2005051423A3 (en) Methods and agents for immune modulation and methods for identifying immune modulators
WO2002037106A3 (en) Methods for comparitive analysis of carbohydrate polymers
WO2006105170A3 (en) Systems and methods for determining cost of capital for an entity in a bottom-up, fully risk-based manner

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
ENP Entry into the national phase

Ref country code: JP

Ref document number: 2001 572869

Kind code of ref document: A

Format of ref document f/p: F

WWE Wipo information: entry into national phase

Ref document number: 2001922998

Country of ref document: EP

AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

WWP Wipo information: published in national office

Ref document number: 2001922998

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 2001922998

Country of ref document: EP